{"database": "openregs", "table": "dockets", "rows": [["FDA-2004-P-0282", "FDA", "Declare that Glipizide and Metformin Hydrochloride Oral Solution, 2.5 mg/250 mg per 5 mL; 2.5 mg/500 mg per 10 mL and 5 mg/500 mg per 10 mL is suitable for submission as an ANDA-CLOSED", "Nonrulemaking", "2021-09-01T01:02:16Z", "0b000064804726d5"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2004-P-0282"], "units": {}, "query_ms": 0.7272649090737104, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}